Detalhe da pesquisa
1.
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Clin Infect Dis
; 78(2): 259-268, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740559
2.
Clinical Outcomes and Bacterial Characteristics of Carbapenem-resistant Acinetobacter baumannii Among Patients From Different Global Regions.
Clin Infect Dis
; 78(2): 248-258, 2024 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738153
3.
In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals.
Antimicrob Agents Chemother
; 68(3): e0125823, 2024 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289078
4.
International Epidemiology of Carbapenemase-Producing Escherichia coli.
Clin Infect Dis
; 77(4): 499-509, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154071
5.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Clin Infect Dis
; 76(3): e1157-e1165, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031403
6.
Transmission of Carbapenem-Resistant Klebsiella pneumoniae in US Hospitals.
Clin Infect Dis
; 76(2): 229-237, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36173830
7.
Ontology-guided segmentation and object identification for developmental mouse lung immunofluorescent images.
BMC Bioinformatics
; 22(1): 82, 2021 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622235
8.
Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV.
Clin Infect Dis
; 68(11): 1823-1830, 2019 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239599
9.
Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 64(suppl_1): S13-S17, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350898
10.
Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 64(suppl_1): S18-S23, 2017 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28350899
11.
Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III.
J Clin Microbiol
; 55(1): 134-144, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27795336
12.
Libraries as 'everyday' settings: the Glasgow MCISS project.
Health Promot Int
; 32(5): 891-900, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27006366
13.
Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME).
Clin Infect Dis
; 63(6): 812-7, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27193750
14.
Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and II.
Clin Infect Dis
; 62(2): 181-9, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409063
15.
Libraries as 'everyday' settings: the Glasgow MCISS project.
Health Promot Int
; 34(1): 177, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29036299
16.
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
Lancet Microbe
; 4(3): e159-e170, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36774938
17.
Correction for Evans et al., "Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS III".
J Clin Microbiol
; 55(6): 1970, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28536161
18.
Changing nursing practice: letting go of the nursing history on admission.
J Nurs Adm
; 42(9): 435-41, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22922754
19.
A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection.
Open Forum Infect Dis
; 9(6): ofac140, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615299
20.
Accessory Genomes Drive Independent Spread of Carbapenem-Resistant Klebsiella pneumoniae Clonal Groups 258 and 307 in Houston, TX.
mBio
; 13(2): e0049722, 2022 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357213